Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,194 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hematologists' barriers and enablers to screening and recruiting patients to a chimeric antigen receptor (CAR) T cell therapy trial: a theory-informed interview study.
Castillo G, Lalu M, Asad S, Foster M, Kekre N, Fergusson D, Hawrysh T, Atkins H, Thavorn K, Montroy J, Schwartz S, Holt R, Broady R, Presseau J; GO CART team. Castillo G, et al. Among authors: fergusson d. Trials. 2021 Mar 25;22(1):230. doi: 10.1186/s13063-021-05121-y. Trials. 2021. PMID: 33766105 Free PMC article.
A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.
Sabloff M, Atkins HL, Bence-Bruckler I, Bredeson C, Fergusson D, Genest P, Hopkins H, Hutton B, Mcdiarmid S, Huebsch LB. Sabloff M, et al. Among authors: fergusson d. Biol Blood Marrow Transplant. 2007 Aug;13(8):956-64. doi: 10.1016/j.bbmt.2007.04.009. Biol Blood Marrow Transplant. 2007. PMID: 17640600 Free article.
A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.
Thavorn K, Coyle D, Hoch JS, Vandermeer L, Mazzarello S, Wang Z, Dranitsaris G, Fergusson D, Clemons M. Thavorn K, et al. Among authors: fergusson d. Support Care Cancer. 2017 Aug;25(8):2505-2513. doi: 10.1007/s00520-017-3658-z. Epub 2017 Mar 9. Support Care Cancer. 2017. PMID: 28281050 Clinical Trial.
Assessment of safety and efficacy of mesenchymal stromal cell therapy in preclinical models of acute myocardial infarction: a systematic review protocol.
Barron CC, Lalu MM, Stewart DJ, Fergusson D, Yang H, Moher D, Liu P, Mazer D, Devereaux PJ, McIntyre L; Canadian Perioperative Anesthesia Clinical Trials Group. Barron CC, et al. Among authors: fergusson d. Syst Rev. 2017 Nov 7;6(1):226. doi: 10.1186/s13643-017-0601-9. Syst Rev. 2017. PMID: 29116020 Free PMC article.
The prevalence of patient engagement in published trials: a systematic review.
Fergusson D, Monfaredi Z, Pussegoda K, Garritty C, Lyddiatt A, Shea B, Duffett L, Ghannad M, Montroy J, Murad MH, Pratt M, Rader T, Shorr R, Yazdi F. Fergusson D, et al. Res Involv Engagem. 2018 May 22;4:17. doi: 10.1186/s40900-018-0099-x. eCollection 2018. Res Involv Engagem. 2018. PMID: 29796308 Free PMC article.
1,194 results